C. R. Bard, Elekta AB, and Intuitive Surgical Inc. are three key vendors highlighted in a new Technavio report
London, 25 June 2015 – Technavio has published a new report on the global prostate cancer devices market, which is expected to grow at a CAGR of more than 13% from 2015-2019.
Prostate cancer devices market segmentation by application and region
Technavio’s report analyzes the solutions and products offered by market vendors and presents a comprehensive breakdown of the market by type of application, namely brachytherapy, radical prostatectomy, cryotherapy, HIFU (high-intensity focused ultrasound), and external beam radiation therapy.
Additionally, analysts have segmented market projections by key region, including the Americas, EMEA (Europe, Middle East, and Africa), and APAC (Asia-Pacific).
“The increasing implementation of robotic-assisted technology devices such as the da Vinci system offers numerous advantages to open prostatectomy surgeries because surgeons achieve better precision and mobility in operating the instruments,” says Faisal Ghaus, Vice President of Technavio.
Prostate cancer devices: Market scope and size
This report covers the present scenario and growth prospects of the global prostate cancer devices market for the period 2015-2019. To calculate the market size, we use the revenue generated from the sales of the devices used for treating prostate cancer.
Industry overview
Key vendors:
- C. R. Bard
- Elekta AB
- Intuitive Surgical Inc.
- Siemens Healthcare
- Theragenics Corp.
- Varian Medical Systems
Market growth drivers:
- Increase in aging population
- Rise in incidence of prostate disorders
Market challenges:
- Complications of prostate cancer surgeries
- High cost of treatment
Market trends:
- Increased adoption of robotic prostatectomy
- Advances in technology
View the global prostate cancer devices market report.
https://www.technavio.com/%3Cp%3E%3Ca%20href%3D%22http%3A//www.technavio….
